ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
104,872.22
1.19%
S&P 500
6,100.55
0.23%
Dow Jones
44,467.07
0.70%
US Dollar vs Yen
155.808
-0.40%
Brent Oil
77.365
-1.24%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Prelude Therapeutics Inc (PRLD) 銘柄情報

Prelude Therapeutics Inc

Prelude Therapeutics Inc (PRLD)

NASDAQ
1.12
-0.05
( -4.27% )
更新日時： 05:23:08
15分遅延

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
1.12
買値
1.11
売値
1.12
出来高
131,846
1.05 日の範囲 1.17
0.7966 52 週間の範囲 6.80
時価総額
61.639M
前日終値
1.17
始値
1.13
時刻
100
@
1.12
最終取引時間
05:23:08
財務取引量
US$ 147,055
VWAP
1.1154
平均取引量 (3 か月)
509,307
発行済株式数
55,035,170
配当利回り
-
PER
-0.51
1 株当たり利益 (EPS)
-2.21
歳入
-
純利益
-121.83M

Prelude Therapeutics Inc について

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.preludetx.com
本社
Wilmington, Delaware, USA
設立
-
Prelude Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker PRLD. The last closing price for Prelude Therapeutics was US$1.17. Over the last year, Prelude Therapeutics shares have traded in a share price range of US$ 0.7966 to US$ 6.80.

Prelude Therapeutics currently has 55,035,170 shares in issue. The market capitalisation of Prelude Therapeutics is US$64.39 million. Prelude Therapeutics has a price to earnings ratio (PE ratio) of -0.51.

PRLD 最新ニュース

その他のニュース

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月8日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月3日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月3日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月20日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月20日
Edgar (US Regulatory)

Form 8-K - Current report

2024年12月11日
Edgar (US Regulatory)

Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies

• PRT2527 demonstrated activity across a range of relapsed/refractory lymphoid malignancies, including patients who received prior CAR-T therapy • Prelude plans to seek a partner for future...

2024年12月11日
GlobeNewswire Inc.

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...

2024年11月27日
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月7日
Edgar (US Regulatory)

Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Presented interim data from the ongoing Phase 1 dose escalation study of PRT3789, its first-in-class IV SMARCA2 degrader, demonstrating clinical proof of concept Initiated a Phase 1 trial for...

2024年11月7日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.065.660377358491.061.310.993953171.16524954CS
4-0.18-13.84615384621.31.4750.983818411.21871598CS
12-0.19-14.50381679391.311.590.79665093071.12067937CS
26-3.81-77.28194726174.936.80.79663840272.04877667CS
52-2.23-66.56716417913.356.80.79662306242.40448191CS
156-7.56-87.09677419358.6810.720.79661720744.11433834CS
260-24.64-95.65217391325.7695.3750.796620878016.39947356CS

PRLD - Frequently Asked Questions (FAQ)

What is the current Prelude Therapeutics share price?
The current share price of Prelude Therapeutics is US$ 1.12
How many Prelude Therapeutics shares are in issue?
Prelude Therapeutics has 55,035,170 shares in issue
What is the market cap of Prelude Therapeutics?
The market capitalisation of Prelude Therapeutics is USD 64.39M
What is the 1 year trading range for Prelude Therapeutics share price?
Prelude Therapeutics has traded in the range of US$ 0.7966 to US$ 6.80 during the past year
What is the PE ratio of Prelude Therapeutics?
The price to earnings ratio of Prelude Therapeutics is -0.51
What is the reporting currency for Prelude Therapeutics?
Prelude Therapeutics reports financial results in USD
What is the latest annual profit for Prelude Therapeutics?
The latest annual profit of Prelude Therapeutics is USD -121.83M
What is the registered address of Prelude Therapeutics?
The registered address for Prelude Therapeutics is 200 POWDER MILL ROAD, WILMINGTON, DELAWARE, 19803
What is the Prelude Therapeutics website address?
The website address for Prelude Therapeutics is www.preludetx.com
Which industry sector does Prelude Therapeutics operate in?
Prelude Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
DWTXDogwood Therapeutics Inc
US$ 16.1501
(476.79%)
97.75M
RNAZTransCode Therapeutics Inc
US$ 10.52
(201.43%)
7.7M
HEPAHepion Pharmaceuticals Inc
US$ 0.2315
(71.48%)
500.68M
DGNXDiginex Ltd
US$ 11.85
(58.00%)
9.53M
NITON2OFF Inc
US$ 1.24
(54.04%)
118.56M
CHSNChanson International Holding
US$ 0.884
(-85.97%)
18.31M
JUNSJupiter Neurosciences Inc
US$ 1.4499
(-59.50%)
10.6M
ICONIcon Energy Corporation
US$ 0.533501
(-59.27%)
13.32M
SDSTStardust Power Inc
US$ 1.2001
(-37.82%)
1.43M
BACKIMAC Holdings Inc
US$ 0.8699
(-35.32%)
352.36k
HEPAHepion Pharmaceuticals Inc
US$ 0.2315
(71.48%)
500.68M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.341101
(6.93%)
143.75M
RGTIRigetti Computing Inc
US$ 13.43
(-3.45%)
122.82M
NVDANVIDIA Corporation
US$ 146.44
(-0.43%)
120.51M
RIMEAlgorhythm Holdings Inc
US$ 0.0336
(1.20%)
118.59M

PRLD Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
PRLD
Prelude Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有